A 3-day-old newborn is admitted to the NICU with suspected sepsis. The infant presents with temperature instability, poor feeding, lethargy, and increased work of breathing. Blood cultures are pending. Which nursing intervention should be the highest priority?

In neonatal sepsis, administering antibiotics after blood cultures is the priority to treat infection. Isolation is important but secondary to initiating treatment.

Clinical Priority Setting in Neonatal Sepsis

In the management of suspected neonatal sepsis, the clinical presentation of temperature instability, poor feeding, lethargy, and increased work of breathing signals a systemic inflammatory response that can rapidly progress to septic shock. The pathophysiology involves a dysregulated host response to infection, leading to capillary leak, vasodilation, and myocardial dysfunction. In neonates, the immature immune system and limited physiological reserves make this progression exceptionally swift. The highest priority nursing intervention is the timely administration of prescribed broad-spectrum antibiotics, as the cornerstone of sepsis management is early and appropriate antimicrobial therapy to achieve source control and interrupt the bacterial cascade.

The rationale for administering antibiotics immediately after blood cultures are obtained, rather than delaying until results return, is firmly grounded in evidence-based guidelines. The Infectious Diseases Society of America (IDSA) clinical practice guidelines emphasize that for catheter-related bloodstream infections and other serious bacterial infections, prompt initiation of empirical therapy is critical to reducing mortality ^[1]. Delays in antibiotic administration are associated with increased mortality, particularly in vulnerable populations such as neonates. The blood culture is obtained first to avoid sterilization of the sample, which would prevent identification of the causative organism and subsequent tailoring of therapy, but this step must not delay the first dose of the antibiotic.

The growing threat of multidrug-resistant (MDR) organisms in neonatal intensive care units (NICUs) further underscores the importance of this approach. A narrative review on neonatal MDR infections highlights that prolonged hospitalization, invasive interventions, and prior broad-spectrum antibiotic exposure promote colonization and infection with resistant bacteria ^[4]. Therefore, the initial antibiotic choice must be broad enough to cover likely pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), while cultures are pending. The IDSA guidelines for MRSA infections provide a framework for selecting appropriate empirical coverage when risk factors for resistant organisms are present, reinforcing the principle that early, targeted therapy is essential ^[2]. A systematic review and meta-analysis on antimicrobial resistance (AMR) mitigation strategies in newborns further supports that optimizing antibiotic use—starting with timely, appropriate empirical therapy and then de-escalating based on culture results—is a key strategy to reduce AMR and improve outcomes .

While the other listed interventions are important components of care, they are secondary to antibiotic administration. Monitoring vital signs every 15 minutes and documenting trends (option 2) is necessary for ongoing assessment but does not treat the underlying infection. Providing supplemental oxygen to maintain saturations above 95% (option 3) addresses the symptom of increased work of breathing and hypoxemia but is a supportive measure, not the definitive treatment. Implementing strict isolation precautions (option 4) is a critical infection control measure to prevent transmission, as highlighted by the concern for MDR organism spread in NICUs ^[4], but it is not the immediate, life-saving priority for the individual patient in the acute phase of suspected sepsis. The nurse must prioritize the intervention that directly halts the progression of the septic process, which is the rapid initiation of antibiotic therapy ^[1].